blog

Iraq medical device registration is an essential step for manufacturers, healthcare companies, and international suppliers planning to introduce medical devices, diagnostic products, surgical instruments, or healthcare equipment into the Iraqi market. The process involves more than submitting a product catalogue or obtaining an import permit. Depending on the device and the intended sales channel, a

The drug registration process in Iraq represents the foundational requirement for any pharmaceutical manufacturer seeking to legally market products in the country. With a pharmaceutical market exceeding USD 3 billion annually and private-sector sales reaching approximately USD 2.8 billion in 2025, Iraq offers substantial opportunities for international companies. However, the medicine registration Iraq framework involves multiple regulatory authorities, comprehensive

Entering the Iraqi pharmaceutical market represents a significant strategic opportunity for international manufacturers and healthcare brands. With a population exceeding 44.5 million—the second-largest in the Arab world—and a healthcare sector undergoing sustained transformation, Iraq offers substantial demand for imported medicines, healthcare products, and specialized treatments. The country’s pharmaceutical market has demonstrated remarkable growth, with private-sector sales

Iraq’s healthcare sector is entering a period of gradual transformation. Growing demand for medicines, medical supplies, diagnostic technologies, preventive healthcare, and higher-quality private services is creating opportunities for international manufacturers and healthcare brands. However, success requires more than identifying demand. Companies must understand the country’s regulatory environment, procurement channels, geographic differences, customer expectations, and distribution

The Iraq pharmaceutical market size reflects one of the most significant healthcare opportunities in the Middle East. A large and growing population, increasing demand for chronic-disease treatments, reliance on imported medicines, developing private healthcare services, and renewed interest in local pharmaceutical production are all shaping the market. However, companies researching Iraq often encounter different estimates